Literature DB >> 18854865

GAB2 is not associated with late-onset Alzheimer's disease in Japanese.

Akinori Miyashita1, Hiroyuki Arai, Takashi Asada, Masaki Imagawa, Mikio Shoji, Susumu Higuchi, Katsuya Urakami, Shinichi Toyabe, Kohei Akazawa, Ichiro Kanazawa, Yasuo Ihara, Ryozo Kuwano.   

Abstract

The varepsilon4 allele of the apolipoprotein E gene (APOE) is unequivocally recognized as a genetic risk factor for late-onset Alzheimer's disease (LOAD). Recently, single-nucleotide polymorphisms (SNPs) of the GRB2-associated binding protein 2 gene (GAB2) were shown to be associated with LOAD in Caucasians carrying the APOE-varepsilon4 allele through a genome-wide association study. Here, we attempted to replicate the finding by genotyping these SNPs in a large clinical cohort of Japanese. We observed no association of any of the SNPs with LOAD. GAB2 may not be a disease susceptibility gene for LOAD in Japanese.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854865      PMCID: PMC2986257          DOI: 10.1038/ejhg.2008.181

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

1.  The effects of human population structure on large genetic association studies.

Authors:  Jonathan Marchini; Lon R Cardon; Michael S Phillips; Peter Donnelly
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

2.  The number of trait loci in late-onset Alzheimer disease.

Authors:  E W Daw; H Payami; E J Nemens; D Nochlin; T D Bird; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.

Authors:  Lars Bertram; Matthew B McQueen; Kristina Mullin; Deborah Blacker; Rudolph E Tanzi
Journal:  Nat Genet       Date:  2007-01       Impact factor: 38.330

4.  A genome-wide association study identifies novel risk loci for type 2 diabetes.

Authors:  Robert Sladek; Ghislain Rocheleau; Johan Rung; Christian Dina; Lishuang Shen; David Serre; Philippe Boutin; Daniel Vincent; Alexandre Belisle; Samy Hadjadj; Beverley Balkau; Barbara Heude; Guillaume Charpentier; Thomas J Hudson; Alexandre Montpetit; Alexey V Pshezhetsky; Marc Prentki; Barry I Posner; David J Balding; David Meyre; Constantin Polychronakos; Philippe Froguel
Journal:  Nature       Date:  2007-02-11       Impact factor: 49.962

5.  APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Authors:  Oye Gureje; Adesola Ogunniyi; Olusegun Baiyewu; Brandon Price; Frederick W Unverzagt; Rebecca M Evans; Valerie Smith-Gamble; Kathleen A Lane; Sujuan Gao; Kathleen S Hall; Hugh C Hendrie; Jill R Murrell
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

6.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Association study of the GAB2 gene with the risk of developing Alzheimer's disease.

Authors:  Julien Chapuis; Didier Hannequin; Florence Pasquier; Peter Bentham; Alexis Brice; Isabelle Leber; Thierry Frebourg; Jean-François Deleuze; Emmanuelle Cousin; Uma Thaker; Philippe Amouyel; David Mann; Corinne Lendon; Dominique Campion; Jean-Charles Lambert
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

View more
  10 in total

Review 1.  The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease.

Authors:  Xiao-Ling Pan; Ru-Jing Ren; Gang Wang; Hui-Dong Tang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.

Authors:  Winnie S Liang; Kewei Chen; Wendy Lee; Kunal Sidhar; Jason J Corneveaux; April N Allen; Amanda Myers; Stephen Villa; Bessie Meechoovet; Jeremy Pruzin; Daniel Bandy; Adam S Fleisher; Jessica B S Langbaum; Matthew J Huentelman; Kendall Jensen; Travis Dunckley; Richard J Caselli; Susan Kaib; Eric M Reiman
Journal:  Neuroimage       Date:  2010-10-01       Impact factor: 6.556

3.  Identification of hub genes related to the progression of type 1 diabetes by computational analysis.

Authors:  G Prashanth; Basavaraj Vastrad; Anandkumar Tengli; Chanabasayya Vastrad; Iranna Kotturshetti
Journal:  BMC Endocr Disord       Date:  2021-04-07       Impact factor: 2.763

4.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

5.  GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han.

Authors:  Kangguang Lin; Muni Tang; Haiying Han; Yangbo Guo; Yuhua Lin; Cui Ma
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

6.  Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.

Authors:  Weidong Ji; Lanling Xu; Haiyun Zhou; Suishan Wang; Yan Fang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 7.  Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-10-17       Impact factor: 4.458

8.  The impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer's disease.

Authors:  Xiao-Xiao Chen; Run-Rong Guo; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

9.  Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.

Authors:  Fanggeng Zou; Olivia Belbin; Minerva M Carrasquillo; Oliver J Culley; Talisha A Hunter; Li Ma; Gina D Bisceglio; Mariet Allen; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Kevin Morgan; Steven G Younkin
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Genetics of Alzheimer's disease: recent advances.

Authors:  Dimitrios Avramopoulos
Journal:  Genome Med       Date:  2009-03-27       Impact factor: 11.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.